<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F = female; M = male; n/a = not applicable; relapsing patients = multiple sclerosis patients in the relapsing phase; remitting patients = multiple sclerosis patients in the remitting phase; TWMLL = total white matter lesion loads; the same abbreviations are used for all figures and tables.</p><p>The demographic and clinical characteristics of the study population.</p
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>Values are expressed as mean (Standard deviation).</p><p>RR: relapsing remitting; SP: secondary p...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>M, male; F, female; yrs, years; R, relapsing; P, progressive; MSSS, Multiple.</p><p>Sclerosis Sev...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Definition of relapsing-remitting multiple sclerosis according to Poser et al. <a href="http://ww...
<p>Key: RRMS: relapsing-remitting multiple sclerosis; m: male; f: female; EDSS: Expanded Disability ...
<p>Abbreviations: HCs = healthy controls; MS PT = multiple sclerosis at pre-treatment; EDSS = Expand...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p>Data shown are median and range, except specified. ARR: Annual relapse rate; EDSS: Expanded disab...
<p>Data are presented as mean ± SD, unless otherwise indicated. Abbreviations: RR-MS = relapsing-rem...
<p>DMT: disease-modifying therapy; PDDS: Patient Determined Disease Steps scale; RRMS: relapsing-rem...
<p>Data are reported as mean ±SE.</p><p>Abbreviations used: MS, multiple sclerosis; m, male; f, fema...
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>Values are expressed as mean (Standard deviation).</p><p>RR: relapsing remitting; SP: secondary p...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>M, male; F, female; yrs, years; R, relapsing; P, progressive; MSSS, Multiple.</p><p>Sclerosis Sev...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>Definition of relapsing-remitting multiple sclerosis according to Poser et al. <a href="http://ww...
<p>Key: RRMS: relapsing-remitting multiple sclerosis; m: male; f: female; EDSS: Expanded Disability ...
<p>Abbreviations: HCs = healthy controls; MS PT = multiple sclerosis at pre-treatment; EDSS = Expand...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p>Data shown are median and range, except specified. ARR: Annual relapse rate; EDSS: Expanded disab...
<p>Data are presented as mean ± SD, unless otherwise indicated. Abbreviations: RR-MS = relapsing-rem...
<p>DMT: disease-modifying therapy; PDDS: Patient Determined Disease Steps scale; RRMS: relapsing-rem...
<p>Data are reported as mean ±SE.</p><p>Abbreviations used: MS, multiple sclerosis; m, male; f, fema...
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>Values are expressed as mean (Standard deviation).</p><p>RR: relapsing remitting; SP: secondary p...